Literature DB >> 29429995

miR-125b-5p and miR-99a-5p downregulate human γδ T-cell activation and cytotoxicity.

Yuli Zhu1,2, Siya Zhang1, Zinan Li1, Huaishan Wang1, Zhen Li1, Yu Hu1, Hui Chen1, Xuan Zhang3, Lianxian Cui1, Jianmin Zhang4, Wei He5.   

Abstract

As an important component of innate immunity, human circulating γδ T cells function in rapid responses to infections and tumorigenesis. MicroRNAs (miRNAs) play a critical regulatory role in multiple biological processes and diseases. Therefore, how the functions of circulating human γδ T cells are regulated by miRNAs merits investigation. In this study, we profiled the miRNA expression patterns in human peripheral γδ T cells from 21 healthy donors and identified 14 miRNAs that were differentially expressed between peripheral αβ T cells and γδ T cells. Of the 14 identified genes, 7 miRNAs were downregulated, including miR-150-5p, miR-450a-5p, miR-193b-3p, miR-365a-3p, miR-31-5p, miR-125b-5p and miR-99a-5p, whereas the other 7 miRNAs were upregulated, including miR-34a-5p, miR-16-5p, miR-15b-5p, miR-24-3p, miR-22-3p, miR-22-5p and miR-9-5p, in γδ T cells compared with αβ T cells. In subsequent functional studies, we found that both miR-125b-5p and miR-99a-5p downregulated γδ T cell activation and cytotoxicity to tumor cells. Overexpression of miR-125b-5p or miR-99a-5p in γδ T cells inhibited γδ T cell activation and promoted γδ T cell apoptosis. Additionally, miR-125b-5p knockdown facilitated the cytotoxicity of γδ T cells toward tumor cells in vitro by increasing degranulation and secretion of IFN-γ and TNF-α. Our findings improve the understanding of the regulatory functions of miRNAs in γδ T cell activation and cytotoxicity, which has implications for interventional approaches to γδ T cell-mediated cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29429995      PMCID: PMC6355834          DOI: 10.1038/cmi.2017.164

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  49 in total

1.  MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output.

Authors:  Ryan M O'Connell; Aadel A Chaudhuri; Dinesh S Rao; William S J Gibson; Alejandro B Balazs; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

2.  Cardiomyogenesis is controlled by the miR-99a/let-7c cluster and epigenetic modifications.

Authors:  Antonietta Coppola; Antonio Romito; Christelle Borel; Corinne Gehrig; Maryline Gagnebin; Emilie Falconnet; Antonella Izzo; Lucia Altucci; Sandro Banfi; Stylianos E Antonarakis; Gabriella Minchiotti; Gilda Cobellis
Journal:  Stem Cell Res       Date:  2013-11-28       Impact factor: 2.020

Review 3.  Immunosurveillance and immunoregulation by gammadelta T cells.

Authors:  Michael Girardi
Journal:  J Invest Dermatol       Date:  2006-01       Impact factor: 8.551

4.  Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance.

Authors:  Hiroshi Tanaka; Evelyn Kono; Chau P Tran; Hideyo Miyazaki; Joyce Yamashiro; Tatsuya Shimomura; Ladan Fazli; Robert Wada; Jiaoti Huang; Robert L Vessella; Jaibin An; Steven Horvath; Martin Gleave; Matthew B Rettig; Zev A Wainberg; Robert E Reiter
Journal:  Nat Med       Date:  2010-11-07       Impact factor: 53.440

5.  Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies.

Authors:  Jianhua Zhou; Ning Kang; Lianxian Cui; Denian Ba; Wei He
Journal:  Cell Mol Immunol       Date:  2011-06-13       Impact factor: 11.530

6.  MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R.

Authors:  J Gong; J-P Zhang; B Li; C Zeng; K You; M-X Chen; Y Yuan; S-M Zhuang
Journal:  Oncogene       Date:  2012-07-23       Impact factor: 9.867

7.  miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3.

Authors:  Li-hong Liu; Hui Li; Jin-ping Li; Hui Zhong; Han-chon Zhang; Jia Chen; Tao Xiao
Journal:  Biochem Biophys Res Commun       Date:  2011-11-10       Impact factor: 3.575

8.  Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease.

Authors:  Bin Xiao; Yu Wang; Wei Li; Megan Baker; Jian Guo; Kelly Corbet; Ephraim L Tsalik; Qi-Jing Li; Scott M Palmer; Christopher W Woods; Zhiguo Li; Nelson J Chao; You-Wen He
Journal:  Blood       Date:  2013-09-16       Impact factor: 22.113

9.  MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb.

Authors:  Changchun Xiao; Dinis Pedro Calado; Gunther Galler; To-Ha Thai; Heide Christine Patterson; Jing Wang; Nikolaus Rajewsky; Timothy P Bender; Klaus Rajewsky
Journal:  Cell       Date:  2007-10-05       Impact factor: 41.582

10.  Inhibition of the glucocorticoid receptor results in an enhanced miR-99a/100-mediated radiation response in stem-like cells from human prostate cancers.

Authors:  Jayant K Rane; Holger H H Erb; Giovanna Nappo; Vincent M Mann; Matthew S Simms; Anne T Collins; Tapio Visakorpi; Norman J Maitland
Journal:  Oncotarget       Date:  2016-08-09
View more
  19 in total

Review 1.  Functional Role of MicroRNAs in Thymocyte Development.

Authors:  Lin Hu; Ling Mao; Shiming Liu; Juanjuan Zhao; Chao Chen; Mengmeng Guo; Zhixu He; Jie Yang; Wei Xu; Lin Xu
Journal:  Int Arch Allergy Immunol       Date:  2019-03-12       Impact factor: 2.749

2.  Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapy.

Authors:  Vivian Bonezi; Fabiana Dalla Vecchia Genvigir; Patrícia de Cássia Salgado; Claudia Rosso Felipe; Helio Tedesco-Silva; José Osmar Medina-Pestana; Alvaro Cerda; Sonia Quateli Doi; Mario Hiroyuki Hirata; Rosario Dominguez Crespo Hirata
Journal:  Ann Transl Med       Date:  2020-09

3.  microRNA-99a Restricts Replication of Hepatitis C Virus by Targeting mTOR and de novo Lipogenesis.

Authors:  Eun Byul Lee; Pil Soo Sung; Jung-Hee Kim; Dong Jun Park; Wonhee Hur; Seung Kew Yoon
Journal:  Viruses       Date:  2020-06-27       Impact factor: 5.048

4.  Different Diets Change the Expression of Bovine Serum Extracellular Vesicle-miRNAs.

Authors:  Suyu Quan; Xuemei Nan; Kun Wang; Linshu Jiang; Junhu Yao; Benhai Xiong
Journal:  Animals (Basel)       Date:  2019-12-13       Impact factor: 2.752

Review 5.  The Emerging Roles of miR-125b in Cancers.

Authors:  Ying Wang; Guilin Zeng; Yicheng Jiang
Journal:  Cancer Manag Res       Date:  2020-02-12       Impact factor: 3.989

6.  Silencing miR-125b-5p attenuates inflammatory response and apoptosis inhibition in mycobacterium tuberculosis-infected human macrophages by targeting DNA damage-regulated autophagy modulator 2 (DRAM2).

Authors:  Guangming Liu; Qiufeng Wan; Jingwen Li; Xinying Hu; Xingli Gu; Sicheng Xu
Journal:  Cell Cycle       Date:  2020-10-30       Impact factor: 4.534

7.  Inhibition of miR-99a-5p prevents allergen-driven airway exacerbations without compromising type-2 memory responses in the intestine following helminth infection.

Authors:  Lewis Entwistle; Helena Aegerter; Stephanie Czieso; Eleni Amaniti; Riccardo Guidi; Abdul Sesay; Nikolay Nikolov; Probir Chakravaty; Alison Huynh; Jessica Mills; Sean Flanagan; Shannon Hambro; Victor Nunez; Yi Cao; Christine Clarke; Angela Martzall; Laurie Leong; Dennis Wilson; Cary Austin; Mark Wilson
Journal:  Mucosal Immunol       Date:  2021-04-12       Impact factor: 7.313

8.  Comprehensive analysis of long non‑coding RNA using an associated competitive endogenous RNA network in Wilms tumor.

Authors:  Zhichao Wang; Huiyan Cheng; Lingli Qi; Dayun Sui
Journal:  Mol Med Rep       Date:  2020-05-05       Impact factor: 2.952

9.  CD137 costimulation enhances the antiviral activity of Vγ9Vδ2-T cells against influenza virus.

Authors:  Yujun Pei; Kun Wen; Zheng Xiang; Chunyu Huang; Xiwei Wang; Xiaofeng Mu; Liyan Wen; Yinping Liu; Wenwei Tu
Journal:  Signal Transduct Target Ther       Date:  2020-06-03

10.  Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR / ALK wild-type advanced non-small cell lung cancer.

Authors:  Xiao-Xiao Peng; Ruoying Yu; Xue Wu; Shu-Yu Wu; Can Pi; Zhi-Hong Chen; Xu-Chao Zhang; Cun-Yi Gao; Yang W Shao; Li Liu; Yi-Long Wu; Qing Zhou
Journal:  J Immunother Cancer       Date:  2020-01       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.